https://www.selleckchem.com/pr....oducts/ldn-212854.ht
During the 5-year time period, prevalence ranged from 2.32 (95% CI 2.06-2.6 in 2015 to 2.91 (95% CI 2.39-3.47) in 2012. The prevalence of MS in China was lower than that in Europe and North America. The temporal trend of prevalence in China was also observed to be stable. As the first prevalence study of MS in mainland China, this population-based study can provide useful information for worldwide healthcare services and prevention of MS. The prevalence of MS in China was lower than that in Europe and North America. The temporal tr
Like
Comment
Share
